We are live on ! Find out more
SC

Samlyn Capital Portfolio holdings

AUM $6.14B
1-Year Est. Return 42.05%
This Fund
S&P 500
This Quarter Est. Return
+16.21%
1 Year Est. Return
+42.05%
3 Year Est. Return
+148.08%
5 Year Est. Return
+210.34%
10 Year Est. Return
+1,110.53%
AUM
$4B
AUM Growth
+$415M
Cap. Flow
-$128M
Cap. Flow %
-3.19%
Top 10 Hldgs %
28.38%
Holding
120
New
31
Increased
28
Reduced
25
Closed
31

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$105M
2
A icon
Agilent Technologies
A
+$66.8M
3
CVS icon
CVS Health
CVS
+$65.2M
4
TROW icon
T. Rowe Price
TROW
+$63.2M
5
ULTA icon
Ulta Beauty
ULTA
+$59.3M

Sector Composition

Rank Sector Weight
1 Healthcare 23.33%
2 Consumer Discretionary 18.58%
3 Financials 17.02%
4 Industrials 7.74%
5 Real Estate 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRF
1
DELISTED
NorthStar Realty Finance Corp.
NRF
$151M 3.77%
5,710,199
+2,440,951
+75% +$49.3M
HOUS
2
DELISTED
Anywhere Real Estate
HOUS
$132M 3.3%
2,666,091
-717,113
-21% -$32.4M
CLGX
3
DELISTED
Corelogic, Inc.
CLGX
$131M 3.28%
3,687,136
+186,290
+5% +$6.06M
EBAY icon
4
eBay
EBAY
$47.1B
$118M 2.94%
5,091,633
+1,250,537
+33% +$27.7M
AGN
5
DELISTED
Allergan plc
AGN
$115M 2.89%
686,500
+173,400
+34% +$27.1M
TMO icon
6
Thermo Fisher Scientific
TMO
$229B
$114M 2.86%
1,026,437
+28,335
+3% +$2.82M
C icon
7
Citigroup
C
$232B
$108M 2.71%
+2,081,017
New +$105M
A icon
8
Agilent Technologies
A
$42.3B
$88.4M 2.21%
2,161,582
+1,757,979
+436% +$66.8M
KATE
9
DELISTED
Kate Spade & Company
KATE
$88.4M 2.21%
2,755,342
+237,844
+9% +$7.01M
STZ icon
10
Constellation Brands
STZ
$22B
$87.9M 2.2%
1,248,497
+339,332
+37% +$22.7M
ANDV
11
DELISTED
Andeavor
ANDV
$82.3M 2.06%
1,406,421
-537,829
-28% -$28M
ULTA icon
12
Ulta Beauty
ULTA
$23.8B
$82.3M 2.06%
852,156
+505,886
+146% +$59.3M
LVNTA
13
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$81.6M 2.04%
2,710,066
+330,797
+14% +$8.88M
CI icon
14
Cigna
CI
$75.6B
$78.9M 1.98%
902,148
+106,048
+13% +$8.68M
CMCSK
15
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$78M 1.95%
1,563,389
+76,261
+5% +$3.8M
DHR icon
16
Danaher
DHR
$148B
$73.6M 1.84%
1,419,250
-270,938
-16% -$13.3M
MCK icon
17
McKesson
MCK
$107B
$73.5M 1.84%
455,433
-175,934
-28% -$27M
PARA
18
DELISTED
Paramount Global Class B
PARA
$72.6M 1.82%
1,139,637
+14,619
+1% +$860K
CVS icon
19
CVS Health
CVS
$124B
$72.6M 1.82%
+1,014,250
New +$65.2M
SGI
20
Somnigroup International
SGI
$14.6B
$71M 1.78%
5,263,032
-1,269,540
-19% -$14.6M
ABBV icon
21
AbbVie
ABBV
$460B
$70.6M 1.77%
1,336,253
-652,217
-33% -$32.1M
TROW icon
22
T. Rowe Price
TROW
$23.7B
$70.6M 1.77%
842,376
+807,376
+2,307% +$63.2M
MET icon
23
MetLife
MET
$63.1B
$68.5M 1.72%
1,425,991
+166,729
+13% +$7.47M
CYN
24
DELISTED
CITY NATIONAL CORPORATION
CYN
$61.6M 1.54%
777,836
-70,463
-8% -$5.2M
AET
25
DELISTED
Aetna Inc
AET
$60.6M 1.52%
883,031
-310,412
-26% -$20.3M

Similar funds

Samlyn Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Samlyn Capital held 120 positions worth $4B, up 12% from $3.58B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Samlyn Capital withdrew a net $128M in Q4 2013, closing 31 positions and reducing 25 holdings. Its most notable exit was Tenet Healthcare, an estimated $96.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Samlyn Capital opened a new position in Citigroup worth $108M.

  • Samlyn Capital's largest Q4 2013 buy was Citigroup: 2,081,017 shares worth $108M.
  • Samlyn Capital added most to Agilent Technologies in Q4 2013, an estimated $66.8M increase.
  • Samlyn Capital's biggest Q4 2013 reduction was APA Corp, cutting an estimated $54.6M.
  • Samlyn Capital fully exited Tenet Healthcare in Q4 2013, selling an estimated $96.4M.
  • Samlyn Capital's ten largest holdings make up 28% of its $4B portfolio in Q4 2013.
  • Samlyn Capital opened 31 new positions and closed 31 in Q4 2013.
  • Samlyn Capital's portfolio value rose 12% quarter-over-quarter to $4B.

Based on Samlyn Capital's 13F filing for Q4 2013, filed 14 Feb 2014.